Cardiac Resynchronization Therapy in CKD Stage 4 Patients

scientific article

Cardiac Resynchronization Therapy in CKD Stage 4 Patients is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.2215/CJN.00620115
P8608Fatcat IDrelease_gcvlht7dzfa6xh3blgpr2bmpye
P932PMC publication ID4594056
P698PubMed publication ID26408549

P50authorNina Ajmone MarsanQ79465156
Martin Jan SchalijQ89053249
Jeroen Joost BaxQ77085900
P2093author name stringVictoria Delgado
Enno T van der Velde
Ulas Höke
Mand J H Khidir
P2860cites workEffects of resynchronization therapy on sympathetic activity in patients with depressed ejection fraction and intraventricular conduction delay due to ischemic or idiopathic dilated cardiomyopathyQ78039342
Clinical versus echocardiographic parameters to assess response to cardiac resynchronization therapyQ82404923
Renal function and mortality following cardiac resynchronization therapyQ82414338
Persistent hemodynamic benefits of cardiac resynchronization therapy with disease progression in advanced heart failureQ83345954
European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)Q84143572
Renal insufficiency and heart failure: prognostic and therapeutic implications from a prospective cohort studyQ28167204
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratificationQ29547560
A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study GroupQ29614889
2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm AssociQ33162947
Importance of venous congestion for worsening of renal function in advanced decompensated heart failureQ33799478
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology,Q34125322
Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failureQ34321811
Recommendations for chamber quantificationQ34491436
Cardiac resynchronization therapy in the cardiorenal syndromeQ35055236
Role of diminished renal function in cardiovascular mortality: marker or pathogenetic factor?Q36357265
Influence of diabetes on left ventricular systolic and diastolic function and on long-term outcome after cardiac resynchronization therapyQ36720290
Cardiac resynchronization therapy in CKD: a systematic reviewQ37065585
Cardiac resynchronization therapy improves renal function in human heart failure with reduced glomerular filtration rateQ37280350
Cardiorenal syndromeQ37324890
Device therapy in heart failure patients with chronic kidney diseaseQ37919633
Effects of cardiac resynchronization therapy on systemic inflammation and neurohormonal pathways in heart failureQ43233275
Renal function as a predictor of outcome in a broad spectrum of patients with heart failureQ43500856
Increased central venous pressure is associated with impaired renal function and mortality in a broad spectrum of patients with cardiovascular disease.Q45929238
Mechanism of improvement in mitral regurgitation after cardiac resynchronization therapyQ47884470
Chronic cardiac resynchronization therapy reverses cardiac remodelling and improves invasive haemodynamics of patients with severe heart failure on optimal medical treatmentQ47955730
Hemodynamic changes during cardiac resynchronization therapyQ48228451
The effect of cardiac resynchronization therapy on left ventricular diastolic function assessed with speckle-tracking echocardiography.Q50673814
Significant lead-induced tricuspid regurgitation is associated with poor prognosis at long-term follow-up.Q50731032
Prognostic value of renal function in patients with cardiac resynchronization therapy.Q51093345
Hemodynamic effects of long-term cardiac resynchronization therapy: analysis by pressure-volume loops.Q51252076
Left ventricular dyssynchrony predicts response and prognosis after cardiac resynchronization therapy.Q51590015
Impaired Renal Function Is Associated With Echocardiographic Nonresponse and Poor Prognosis After Cardiac Resynchronization TherapyQ57299447
Response to cardiac resynchronization therapy in patients with heart failure and renal insufficiency.Q64983685
Clinical classification of cardiac deathsQ70271211
Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failureQ73199514
P433issue10
P304page(s)1740-1748
P577publication date2015-09-25
P1433published inClinical Journal of the American Society of NephrologyQ15757929
P1476titleCardiac Resynchronization Therapy in CKD Stage 4 Patients
P478volume10

Reverse relations

cites work (P2860)
Q43232841Cardiorenal Resynchronization Therapy: Strengthening the Heart and Kidneys
Q90602756Outcomes of ICDs and CRTs in patients with chronic kidney disease: a meta-analysis of 21,000 patients
Q46160078Prescription of Guideline-Recommended Implantable Cardioverter Defibrillator and Cardiac Resynchronization Therapy Among Patients Hospitalized With Heart Failure and Varying Degrees of Renal Function
Q39019268Publication trends in cachexia and sarcopenia in elderly heart failure patients

Search more.